POSB107 A Retrospective Observational Study of Ibrutinib in Real-Life Settings in France, Using the SNDS Database (OSIRIS)
de Pouvourville, G, Choquet, S, Marchal, C, Belhassen, M, Jacoud, F, Guilmet, C, Dupuis, S, Pierres, M, Levy, V
Published in Value in health (01.01.2022)
Published in Value in health (01.01.2022)
Get full text
Journal Article
POSC91 Economic Burden of Multiple Myeloma According to Treatment Lines in France from 2014 to 2019, the Mylord Study
Borget, I, Guilmet, C, Javelot, M, Pierres, M, Denis, H, Herquelot, E, Raguideau, F, Touzeau, C, Perrot, A, Augusto, V, Lamarsalle, L
Published in Value in health (01.01.2022)
Published in Value in health (01.01.2022)
Get full text
Journal Article
PCN332 PATIENT PERCEPTIONS REGARDING MULTIPLE MYELOMA AND ITS TREATMENT: QUALITATIVE EVIDENCE FROM INTERVIEWS WITH NEWLY DIAGNOSED AND RELAPSED-REFRACTORY PATIENTS IN THE UNITED KINGDOM, FRANCE, AND GERMANY
He, J., Duenas, A., Collacott, H., Lam, A., Gries, K., Kobos, R., Potthoff, D., Guilmet, C., Trevor, N., Tervonen, T.
Published in Value in health (01.05.2020)
Published in Value in health (01.05.2020)
Get full text
Journal Article
CE1 - Cost-Effectiveness of Dabigatran with Real World Effectiveness Evidence
de Pouvourville, G, Guilmet, C, Cohen, AA, Le Dissez, C, Luciani, L, Le Lay, K
Published in Value in health (01.10.2017)
Published in Value in health (01.10.2017)
Get full text
Journal Article
PCN114 - Cost-Effectiveness of Nivolumab in Combination with Ipilimumab in First-Line Treatment of Advanced Melanoma in Three European Countries Using 28-Month Overall Survival from Checkmate 067
Hirst, A, Paly, VF, Diamantogiannis, F, Guilmet, C, Polanco, S C, Sabater, J, Chirita, O
Published in Value in health (01.10.2017)
Published in Value in health (01.10.2017)
Get full text
Journal Article
Cost-Effectiveness of Nivolumab in Combination with Ipilimumab in First-Line Treatment of Advanced Melanoma in Three European Countries Using 28-Month Overall Survival from Checkmate 067
Hirst, A, Paly, VF, Diamantogiannis, F, Guilmet, C, Polanco, S C, Sabater, J, Chirita, O
Published in Value in health (01.10.2017)
Published in Value in health (01.10.2017)
Get full text
Journal Article
Cost-Effectiveness of Dolutegravir/Abacavir/Lamivudine in Hiv-1 Treatment Naive Patients in France
Pialoux, G, Marcelin, A, Cawston, H, Guilmet, C, Laurisse, A, Finkielsztejn, L, Aubin, C
Published in Value in health (01.11.2015)
Published in Value in health (01.11.2015)
Get full text
Journal Article
PIN64 - Cost-Effectiveness of Dolutegravir/Abacavir/Lamivudine in Hiv-1 Treatment Naive Patients in France
Pialoux, G, Marcelin, A, Cawston, H, Guilmet, C, Laurisse, A, Finkielsztejn, L, Aubin, C
Published in Value in health (01.11.2015)
Published in Value in health (01.11.2015)
Get full text
Journal Article
Cost-Effectiveness of Dabigatran with Real World Effectiveness Evidence
de Pouvourville, G, Guilmet, C, Cohen, AA, Le Dissez, C, Luciani, L, Le Lay, K
Published in Value in health (01.10.2017)
Published in Value in health (01.10.2017)
Get full text
Journal Article
Hemodynamic and biochemical monitoring during major liver resection with use of hepatic vascular exclusion
Delva, E, Barberousse, J P, Nordlinger, B, Ollivier, J M, Vacher, B, Guilmet, C, Huguet, C
Published in Surgery (01.03.1984)
Get more information
Published in Surgery (01.03.1984)
Journal Article
ATLAS – Nouvelle méthode d’analyse des lignes de traitements à partir du système national des données de santé : exemple de l’étude MYLORD, sur les patients français atteints du myélome multiple
Laurent, M., Guilmet, C., Javelot, M., Guigand, G., Piérres, M., Augusto, V., Lamarsalle, L., Raguideau, F., Prodel, M.
Published in Revue d'épidémiologie et de santé publique (01.09.2020)
Published in Revue d'épidémiologie et de santé publique (01.09.2020)
Get full text
Journal Article